Get in touch
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
Targeted Solid Tumor NGS Fusion Panel
- Next Generation Sequencing (NGS)
The Targeted Solid Tumor NGS Fusion Panel is an RNA-based next-generation sequencing panel that detects translocations and fusions with known and novel fusion partners of these genes: ALK, BRAF, FGFR1, FGFR2, FGFR3, FGFR4, MET including MET Exon 14 skipping, NOTCH1, NOTCH2, NRG1, NTRK1, NTRK2, NTRK3, PDGFB, PDGFRA, PDGFRB, RAF1, RET, and ROS1.
Specimen Requirements
FFPE tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Storage and Transportation
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.
CPT Code(s)*
81449
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Biomarkers
RNA Sequencing
| Fusions | |||||
|---|---|---|---|---|---|
| MET | RAF1 | ROS1 | FGFR4 | NOTCH1 | NOTCH2 |
| NRG1 | PDGFB | RET | FGFR1 | NTRK1 | NTRK2 |
| NTRK3 | PDGFRA | PDGFRB | ALK | BRAF | FGFR2 |
| FGFR3 | |||||
Last Updated: January 28, 2026